中华外科杂志
中華外科雜誌
중화외과잡지
CHINESE JOURNAL OF SURGERY
2009年
6期
457-460
,共4页
甘辉立%张健群%陈宝田%周其文%顾承雄%黄方炯%王胜洵%郑斯宏%穆军升
甘輝立%張健群%陳寶田%週其文%顧承雄%黃方炯%王勝洵%鄭斯宏%穆軍升
감휘립%장건군%진보전%주기문%고승웅%황방형%왕성순%정사굉%목군승
室间隔破裂%心脏外科手术%心肌梗死
室間隔破裂%心髒外科手術%心肌梗死
실간격파렬%심장외과수술%심기경사
Ventricular septal rupture%Cardiac surgical procedures%Myocardial infarction
目的:探讨提高心肌梗死并发室间隔穿孔(VSR)外科治疗疗效的方法.方法:回顾性分析1994年10月至2007年10月37例接受手术治疗的VSR患者的临床资料.男性24例,女性13例,平均年龄(63.4±7.6)岁.其中VSR修补合并同期冠状动脉再血管化26例(再血管化组),单纯VSR修补11例(单纯修补组).结果:围手术期再血管化组病死率15.4%(4/26),低于单纯修补组的63.6%(7/11),P=0.006.出院患者26例均获得随访,平均随访(34.0±29.8)个月,总随访时间57人年.再血管化组晚期死亡2例,单纯修补组3例.再血管化组6~8年生存率为(64.3 ±21.0)%,单纯修补组4年生存率为(25.0±21.7)%,组间差异有统计学意义.21例患者获得中长期生存,心功能Ⅰ~Ⅱ级17例,Ⅲ~Ⅳ级4例.再发VSR 4例.多因素分析发现未冉血管化、心源性休克、急诊手术为早期死亡危险因子,未再血管化、术后低心排是晚期死亡的危险因子.结论:VSR修补术同期施行再血管化手术可提高围手术期生存率和中长期生存率,合理选择手术时机、手术方法,对提高VSR围手术期生存率、减少VSR再发非常重要.
目的:探討提高心肌梗死併髮室間隔穿孔(VSR)外科治療療效的方法.方法:迴顧性分析1994年10月至2007年10月37例接受手術治療的VSR患者的臨床資料.男性24例,女性13例,平均年齡(63.4±7.6)歲.其中VSR脩補閤併同期冠狀動脈再血管化26例(再血管化組),單純VSR脩補11例(單純脩補組).結果:圍手術期再血管化組病死率15.4%(4/26),低于單純脩補組的63.6%(7/11),P=0.006.齣院患者26例均穫得隨訪,平均隨訪(34.0±29.8)箇月,總隨訪時間57人年.再血管化組晚期死亡2例,單純脩補組3例.再血管化組6~8年生存率為(64.3 ±21.0)%,單純脩補組4年生存率為(25.0±21.7)%,組間差異有統計學意義.21例患者穫得中長期生存,心功能Ⅰ~Ⅱ級17例,Ⅲ~Ⅳ級4例.再髮VSR 4例.多因素分析髮現未冉血管化、心源性休剋、急診手術為早期死亡危險因子,未再血管化、術後低心排是晚期死亡的危險因子.結論:VSR脩補術同期施行再血管化手術可提高圍手術期生存率和中長期生存率,閤理選擇手術時機、手術方法,對提高VSR圍手術期生存率、減少VSR再髮非常重要.
목적:탐토제고심기경사병발실간격천공(VSR)외과치료료효적방법.방법:회고성분석1994년10월지2007년10월37례접수수술치료적VSR환자적림상자료.남성24례,녀성13례,평균년령(63.4±7.6)세.기중VSR수보합병동기관상동맥재혈관화26례(재혈관화조),단순VSR수보11례(단순수보조).결과:위수술기재혈관화조병사솔15.4%(4/26),저우단순수보조적63.6%(7/11),P=0.006.출원환자26례균획득수방,평균수방(34.0±29.8)개월,총수방시간57인년.재혈관화조만기사망2례,단순수보조3례.재혈관화조6~8년생존솔위(64.3 ±21.0)%,단순수보조4년생존솔위(25.0±21.7)%,조간차이유통계학의의.21례환자획득중장기생존,심공능Ⅰ~Ⅱ급17례,Ⅲ~Ⅳ급4례.재발VSR 4례.다인소분석발현미염혈관화、심원성휴극、급진수술위조기사망위험인자,미재혈관화、술후저심배시만기사망적위험인자.결론:VSR수보술동기시행재혈관화수술가제고위수술기생존솔화중장기생존솔,합리선택수술시궤、수술방법,대제고VSR위수술기생존솔、감소VSR재발비상중요.
Objective To explore the way of promoting the efficacy of surgical treatment for ventricular septal rupture (VSR) after acute myocardium infarction in terms of perioperative and long term survival. Methods The clinic data of 37 VSR cases underwent surgical treatment from October 1994 to October 2007 were analyzed retrospectively. There were 24 male and 13 female, and the age was (63.4 ± 7.6) years old. The whole group was divided into the VSR repair plus revascularization group ( group A, 26 cases ) and simple VSR repair group ( group B, 11 cases). Results There were 4 operative deaths in group A ( 15.4% ), 7 deaths in group B ( 63.6% ), P = 0. 006. With the follow-up of ( 34.0 ± 29. 8 ) months ranged from 2 to 103 months of the 26 operational survivors, there were 5 late deaths, of which 2 deaths in group A and 3 deaths in group B. According to the Kaplan-Meier survival curve, the actuarial survival rate at 6 to 8 year was ( 64. 3 ± 21.0 ) % for group A and the actuarial survival rate at 4 year was ( 25.0 ± 21.7 ) % for group B, P=0.011. Of the 21 mid-long term survivors, 17 cases were in NYHA class Ⅰ to Ⅱ and 4 cases in NYHA class Ⅲ to Ⅳ. There were 4 cases suffered from VSR recurrence. According to Logistic regression, the risk factors for the early death were unadoptive of revascularization, cardiogenic shock and emergency surgical procedure, while the risk factors for late death were unadoptive of revascularization and low cardiac output after the procedures. Conclusions VSR repair plus revascularization could improve the perioperative and mid-long term survival for the surgical treatment of VSR. The appropriate timing and procedures of the surgical operation are very important to promote perioperative survival and to prevent VSR recuiTence.